Improving partner engagement in pediatric patient-centered outcomes
Official title: Enhancing Stakeholder Engagement in Pediatric Research
Run by NYU Langone Health · NCT07166913 · Data updated 2026-11-12
We will try a package of enhanced engagement strategies to see if they help stakeholder partners stay involved and improve recruitment, retention, and language access in pediatric patient-centered outcomes studies.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 480 (estimated) |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | September 8, 2025 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | July 31, 2026 |
| Trial ID | NCT07166913 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are PIs overseeing qualifying pediatric patient-centered outcomes studies and their stakeholder partners aged 12 or older who speak English, Spanish, or Chinese.
✕Probably not a fit
People who are not part of qualifying study teams, studies with small targets (<50) or well past early enrollment milestones, stakeholders under 12, or those who do not speak English, Spanish, or Chinese are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
PCOR study teams led by eligible principal investigators will implement a bundled toolkit of enhanced engagement strategies and compare outcomes to standard practice. Eligible study teams must be starting or early in enrollment, target at least 50 participants, and include at least 10 stakeholder partners; stakeholders must be ≥12 years old and speak English, Spanish, or Chinese. The implementation will track stakeholder engagement metrics, protocol indicators such as meeting recruitment and retention goals, and language access improvements, supplemented by key informant interviews. The intervention is coordinated by NYU Langone Health with support from the Patient-Centered Outcomes Research Institute and delivered to participating teams and their stakeholders.
Why it matters
Potential benefit: If successful, this could make pediatric PCOR studies more inclusive and effective by increasing stakeholder involvement, improving recruitment and retention, and expanding language access.
How similar studies have gone: Prior work shows that stakeholder engagement can improve study relevance and recruitment, but using a standardized bundled toolkit across multiple pediatric PCOR studies is relatively novel and not widely tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: In order to be eligible to participate in this study, PIs must oversee a study that meets the following criteria: 1. Studies who either have not started enrollment or are within 1-3 months of the start of enrollment, and within the 25% ceiling for % recruitment target. 2. Studies that have started enrollment must be no further than 25% of projected enrollment timeline of the study (with at least 6 months remaining for enrollment). 3. Target n\>50 participants in study. 4. At least 10 stakeholder partners part of study. The PI's must also be ≥18 years old; In order for study stakeholders to be eligible to participate in this study, an individual must meet all of the following criteria: 1. \>=12 years old; 2. Ability to speak either English, Spanish, or Chinese, and; 3. Part of the study team or serving in an advisory capacity to the study team The same criteria as that used for stakeholder and PI eligibility applies to Key informant (KI) interviews. Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in this study: 1. Not able to complete 6 month follow-up assessment 2. Children who are wards/foster children 3. Not able or willing to provide consent. 4. Concurrent enrollment in another study that is part of this research project. In addition, PI's who meet the following criteria will be excluded from participation in this study: 1\. A lot of experience with stakeholder engagement (based on screener survey question)
Where it's running
-
NYU Langone Health
New York, New York, United States Recruiting
Study contacts
- Principal investigator: H. Shonna Yin, MD, MS — NYU Langone Health
- Study coordinator: H. Shonna Yin, MD, MS
- Email: Hsiang.Yin@nyulangone.org
- Phone: 646-501-4284
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Medial unloader brace after root repair
This study tests whether using a medial unloader brace after arthroscopic medial meniscus posterior root repair helps healing and improves knee outcomes.
-
MAC-STILA: a feasibility test for hip fracture surgery anesthesia
This trial tests whether combining monitored anesthesia care with soft tissue infiltration using local anesthesia can reduce post-operative delirium in adults 65 and older undergoing hip fracture repair.
-
Osimertinib with Cyclosporine A for EGFR-mutant NSCLC
This phase II study tests whether adding cyclosporine A to osimertinib helps people with EGFR-mutant metastatic NSCLC who still have detectable tumor DNA in blood.
-
Histotripsy with chemotherapy and immunotherapy for biliary tract cancer
This pilot test will see if adding histotripsy to chemoimmunotherapy is safe and feasible for adults with biliary tract cancer.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
Virtual Reality Vision Testing for Metamorphopsia and Aniseikonia
A portable virtual reality headset is tested to see if it can more reliably and conveniently measure visual distortions in people with metamorphopsia or aniseikonia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.